Moderna, Inc. (NASDAQ:MRNA) | WebDisclosure

Basculer en Français

11114	Companies
244622	Keywords
172654	Articles
131833	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 09/05/2024 at 14:00, 2 years ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
Moderna's updated COVID-19 mRNA vaccine targeting SARS-CoV-2 variant JN.1 receives positive opinion from CHMP for European Commission authorization decision for 2024-2025 vaccination season

COVID-19 Vaccine European Commission Moderna MRNA Spikevax
BRIEF

published on 09/03/2024 at 14:35, 2 years ago

Moderna Receives MHRA Authorization for Updated COVID-19 Vaccine Targeting JN.1 Variant

COVID-19 Moderna Vaccine JN.1 Variant MHRA
BRIEF

published on 09/03/2024 at 14:35, 2 years ago

Moderna reçoit l'autorisation de la MHRA pour un vaccin COVID-19 mis à jour ciblant la variante JN.1

Moderne COVID 19 Vaccin Variante JN.1 MHRA
PRESS RELEASE

published on 09/03/2024 at 14:30, 2 years ago

Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
MHRA authorizes Moderna's updated COVID-19 vaccine targeting JN.1 variant. Available for NHS and private purchase in the UK. Follows WHO recommendation for JN.1 subvariants

COVID-19 Vaccine Moderna JN.1 Variant MHRA Authorization Private Purchase
BRIEF

published on 09/02/2024 at 13:05, 2 years ago

Taiwan FDA Approves Moderna’s COVID-19 Vaccine Targeting SARS-CoV-2 Variant JN.1

COVID-19 Vaccine Moderna Spikevax Taiwan FDA SARS-CoV-2 JN.1
BRIEF

published on 09/02/2024 at 13:05, 2 years ago

La FDA de Taïwan approuve le vaccin COVID-19 de Moderna ciblant la variante JN.1 du SRAS-CoV-2

Moderne Vaccin Contre Le Covid-19 Spikevax SARS-CoV-2 JN.1 FDA De Taïwan
PRESS RELEASE

published on 09/02/2024 at 13:00, 2 years ago

Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
Moderna receives approval for updated COVID-19 vaccine formulation targeting SARS-CoV-2 variant JN.1 from Taiwan FDA. Regulatory decisions globally expected soon

COVID-19 Vaccine Moderna Spikevax SARS-CoV-2 Variant Taiwan FDA
BRIEF

published on 08/29/2024 at 14:05, 2 years 1 month ago

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination

COVID-19 Moderna Vaccination Health Campaign Public Awareness
BRIEF

published on 08/29/2024 at 14:05, 2 years 1 month ago

Moderna lance une campagne nationale de sensibilisation pour favoriser la vaccination contre la COVID-19

Moderne COVID 19 Vaccination Campagne De Santé Sensibilisation Du Public
PRESS RELEASE

published on 08/29/2024 at 14:00, 2 years 1 month ago

Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination
Moderna launches 'Do It For You & Them' campaign to drive vaccination rates in the U.S. and inform about COVID-19 risks & impact, updated vaccines available for KP.2 variant

COVID-19 Moderna Awareness Campaign KP.2 Variant Vaccination Rates

Accesswire

Published on 10/01/2026 at 23:05, 26 minutes ago

Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 1 hour 31 minutes ago

Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/01/2026 at 19:05, 4 hours 26 minutes ago

PEL 90 Participating Interest Exchange with Chevron
Published on 10/01/2026 at 18:05, 5 hours 26 minutes ago

Bocana Resources Corp. Provides a Corporate Update on Various Projects Currently Underway
Published on 10/01/2026 at 15:28, 8 hours 3 minutes ago

Core Critical Metals Corp. Announces Shareholder Approval of Plan of Arrangement

View all ACCESSWIRE

EQS Group

Published on 10/01/2026 at 23:15, 16 minutes ago

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 2 hours 46 minutes ago

Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 3 hours 1 minute ago

Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 4 hours 36 minutes ago

Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios
Published on 10/01/2026 at 18:53, 4 hours 38 minutes ago

Holding(s) in Company

Les Echos

Published on 10/01/2026 at 19:00, 4 hours 31 minutes ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 19:00, 4 hours 31 minutes ago

AMA CORP PLC réduit sa structure de coûts tout en préservant les fonctions clés de XpertEye
Published on 10/01/2026 at 18:40, 4 hours 51 minutes ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:40, 4 hours 51 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Septembre 2026
Published on 10/01/2026 at 18:07, 5 hours 24 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE